Fairwind said...
I agree 100% Lapilot....Once your Oncologist writes "Metatastic Prostate Cancer, Terminal" into your medical records, then any drug or treatment your doctor and you want to try should be available to you and your insurance (within reason) should pay for it...
There are quite a number of mis-guided "Right-to-try" (RTT) laws recently passed at the state level which have created a new dawn of false hope...it's passed in something like 30 states now. The basis of those laws, all of which have been sponsored by the libertarian Goldwater Institute, allows terminally ill patients to access investigational treatments that have passed basic safety testing (Phase 1) with the FDA, but are not yet available on pharmacy shelves. Under the RTT laws, patients are responsible for costs of their investigational treatments.
The access to drug candidates that have completed no more than a Phase 1 clinical trial is the worst form of false hope that threatens to cost those most vulnerable everything. Because most drug candidates enter Phase 2 (70% pass Phase 1), a proposed cancer drug that kills normal cells too fast or causes side effects that kill a patient more quickly than the cancer will likely progress through at least Phase 2 trials before being dropped from the pipeline. In fact, a patient is far more likely to receive a drug candidate that will have significant adverse side effects beyond the symptoms caused by the disease. Insurance companies are exempt under the RTT laws from paying for medical problems, complications or side-effects...and nobody, not even the lawmakers who passed these laws, believes insurance should be held accountable for the costs of the RTT drugs or the cost of complications.
So, these laws seek to make experimental drugs available on an unbalanced scale to those who can afford anything, but will bankrupt many of those who cannot afford any cost.
In a nod to autonomy and the power of hope, perhaps a more reasonable approach would be to allow patients the right to try drug candidates that have
entered into Phase 3 clinical trials. While many of the problems with cost, insurance and liability would remain, perhaps the most toxic and least effective drug candidates may have been screened from the pool of drug candidates. The current RTT laws are, in my opinion, mis-guided.
NOTE: The RTT laws are
completely outside of the Biden "moonshot" efforts.